Candel Therapeutics (CADL) Receivables - Net: 2020-2021
Historic Receivables - Net for Candel Therapeutics (CADL) over the last 2 years, with Dec 2021 value amounting to $1.1 million.
- Candel Therapeutics' Receivables - Net rose 72.44% to $1.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year increase of 72.44%. This contributed to the annual value of $1.1 million for FY2021, which is 72.44% up from last year.
- As of FY2021, Candel Therapeutics' Receivables - Net stood at $1.1 million, which was up 72.44% from $624,000 recorded in FY2020.
- In the past 5 years, Candel Therapeutics' Receivables - Net registered a high of $1.1 million during FY2021, and its lowest value of $624,000 during FY2020.
- Moreover, its 2-year median value for Receivables - Net was $850,000 (2020), whereas its average is $850,000.
- Data for Candel Therapeutics' Receivables - Net shows a peak YoY spiked of 72.44% (in 2021) over the last 5 years.
- Over the past 2 years, Candel Therapeutics' Receivables - Net (Yearly) stood at $624,000 in 2020, then surged by 72.44% to $1.1 million in 2021.